Scholarlink

Background <p>Patient-Reported Outcomes (PROs) in personalized lung cancer care aim to facilitate a targeted therapeutic management approach. This study explores the implementation of PROs as an intervention component within a precision medicine program, with a focus on identifying facilitating factors and barriers from the perspectives of health care providers (HCPs) and patients with stage IV non-small-cell lung cancer (NSCLC).</p> Methodology <p>Semi-structured individual interviews were conducted with HCPs and NSCLC patients over two rounds in 2023 and 2024, respectively. Verbatim transcripts were analyzed using qualitative content analysis. The framework of Grol and Wensing was employed, which divides healthcare into six dimensions.</p> Results <p>The structured documentation of symptoms and quality of life constitutes a benefit in that it enables intervention by the treating physician. From the perspective of HCPs, incorporating PROs into daily clinical practice was associated with considerable organizational challenges and the need for logins into an additional system to access the results. This required a substantial investment of time and personnel, which resulted in a lack of acceptance. The predominant motivation of patients who participated in the PRO questionnaires was a desire to contribute to scientific research. In general, the regular administration of the questionnaire has proven unfeasible for the NSCLC cohort, given the high disease burden often experienced in stage IV.</p> Conclusions <p>Despite implementation challenges, PROs can improve symptom monitoring, communication, and patient-centered care in advanced NSCLC when key barriers are addressed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月28日

查看全文
  • Vanessa Mildenberger,
  • Dusan Simic,
  • Leonie Eilers,
  • Anika Kästner,
  • Marie Naumann,
  • Anna Rasokat,
  • Anna Kron,
  • Daniel Armbrust,
  • Anna Spier,
  • Neeltje van den Berg,
  • Wolfgang Hoffmann,
  • Jürgen Wolf,
  • Florian Kron,
  • Stephanie Stock

摘要

Background

Patient-Reported Outcomes (PROs) in personalized lung cancer care aim to facilitate a targeted therapeutic management approach. This study explores the implementation of PROs as an intervention component within a precision medicine program, with a focus on identifying facilitating factors and barriers from the perspectives of health care providers (HCPs) and patients with stage IV non-small-cell lung cancer (NSCLC).

Methodology

Semi-structured individual interviews were conducted with HCPs and NSCLC patients over two rounds in 2023 and 2024, respectively. Verbatim transcripts were analyzed using qualitative content analysis. The framework of Grol and Wensing was employed, which divides healthcare into six dimensions.

Results

The structured documentation of symptoms and quality of life constitutes a benefit in that it enables intervention by the treating physician. From the perspective of HCPs, incorporating PROs into daily clinical practice was associated with considerable organizational challenges and the need for logins into an additional system to access the results. This required a substantial investment of time and personnel, which resulted in a lack of acceptance. The predominant motivation of patients who participated in the PRO questionnaires was a desire to contribute to scientific research. In general, the regular administration of the questionnaire has proven unfeasible for the NSCLC cohort, given the high disease burden often experienced in stage IV.

Conclusions

Despite implementation challenges, PROs can improve symptom monitoring, communication, and patient-centered care in advanced NSCLC when key barriers are addressed.